[CLSTR]
API
< Back to situations

[ORGANIZATION]

Merck & Co.

Featured in 17 tracked stories · first seen

Situations

[ACTIVE] [BUSINESS] [US]

Pharmaceutical industry market trends

2 clusters · 2 sources · last updated

Latest: Goldman Sachs analysts maintain bullish outlook on pharmaceutical sector

Major pharmaceutical companies, including AbbVie, Eli Lilly, and Gilead Sciences, have seen stock prices reach or approach record highs. This movement reflects a shift in investor capital from high-risk technology growth

[ACTIVE] [BUSINESS] [US] [CN] [DE]

Moderna and Merck melanoma vaccine clinical trials

19 clusters · 558 sources · last updated

Latest: BioNTech and Moderna face mixed clinical and market outlooks

Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (V940), an experimental personalized mRNA cancer vaccine. The INTerpath-001 trial, which administered the vaccine alon

[QUIET] [BUSINESS] [CN] [IN] [JP]

Global vaccine market growth and technology trends

2 clusters · 5 sources · last updated

Latest: Japan industrial robotics market projected to reach $3.18 billion by 2035

The global vaccine sector is experiencing significant growth across different segments. The vaccine delivery device market is projected to expand from $8.1 billion in 2025 to $17.1 billion by 2035, driven by immunization

[QUIET] [BUSINESS] [US]

Schwab U.S. Dividend Equity ETF performance and strategy

6 clusters · 12 sources · last updated

Latest: Schwab U.S. Dividend Equity ETF highlighted for passive income growth

Investors evaluating dividend-focused exchange-traded funds (ETFs) continue to weigh the Schwab U.S. Dividend Equity ETF (SCHD) against high-yield and growth-oriented alternatives. SCHD maintains a low-cost profile with

[QUIET] [HEALTH] [EU] [IS] [KR]

Keytruda therapeutic expansions and approvals

2 clusters · 24 sources · last updated

Latest: European Commission approves bladder cancer treatment

The immunotherapy drug Keytruda has seen recent developments regarding new formulations and expanded clinical applications. In South Korea, MSD Korea announced the October launch of a subcutaneous (SC) formulation of Ke

[QUIET] [BUSINESS] [US] [CZ] [KR]

Global dividend stock and investment trends

2 clusters · 5 sources · last updated

Latest: Investment trends highlight dividend fund performance and AI-driven tech growth

Market reports indicate varied performance across global dividend-paying stocks and investment funds. In the S&P 500, companies such as Texas Instruments, Merck & Co., and LyondellBasell Industries have shown significant

Also covered in